ŘÍČNÁ, Dita, Martina LENGEROVÁ, Matěj BEZDÍČEK, Iva KOCMANOVÁ, Lubos DRGONA, Barbora WEINBERGEROVÁ, Jiří MAYER and Zdeněk RÁČIL. Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR. Folia microbiologica. Dordrecht: Springer, 2019, vol. 64, No 3, p. 421-428. ISSN 0015-5632. Available from: https://dx.doi.org/10.1007/s12223-018-00669-w.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR
Authors ŘÍČNÁ, Dita (203 Czech Republic, belonging to the institution), Martina LENGEROVÁ (203 Czech Republic, belonging to the institution), Matěj BEZDÍČEK (203 Czech Republic, belonging to the institution), Iva KOCMANOVÁ (203 Czech Republic), Lubos DRGONA (703 Slovakia), Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Zdeněk RÁČIL (203 Czech Republic, belonging to the institution).
Edition Folia microbiologica, Dordrecht, Springer, 2019, 0015-5632.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.730
RIV identification code RIV/00216224:14110/19:00108353
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s12223-018-00669-w
UT WoS 000468847600014
Keywords in English fungal pneumonia
Tags 14110212, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 12/7/2019 16:43.
Abstract
Rapid diagnostics of fungal pneumonia and initiation of appropriate therapy are still challenging. In this study, we used two panfungal assays to test bronchoalveolar lavage fluid (BALF) samples to prove their ability to confirm invasive fungal disease diagnosis and identify causative agents. Two methods targeting different fungal rDNA regions were used, and the obtained PCR products were sequenced directly or after cloning. In total, 106 BALF samples from 104 patients were tested. After sequencing, we obtained 578 sequences. Four hundred thirty-seven sequences were excluded from further analysis due to duplication (n=335) or similarity with sequences detected in the extraction control sample (n=102); 141 unique sequences were analyzed. Altogether, 23/141 (16%) of the fungi detected belonged to pathogenic species, and 63/141 (45%) were identified as various yeasts; a variety of environmental or very rare fungal human pathogens represented 29/141 (21%) of the total and 26/141 (18%) were described as uncultured fungus. Panfungal PCR detected fungal species that would be missed by specific methods in only one case (probable cryptococcosis). Panfungal PCR followed by sequencing has limited use for testing BALF samples due to frequent commensal or environmental fungal species pickup.
Links
MUNI/A/1105/2018, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit VI (Acronym: VýDiTeHeMA VI)
Investor: Masaryk University, Category A
TE02000058, research and development projectName: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)
Investor: Technology Agency of the Czech Republic
PrintDisplayed: 23/7/2024 22:15